Related Experiment Video
Updated: Aug 16, 2025

Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells
Published on: May 22, 2014
Lipoxin A4 attenuates MSU-crystal-induced NLRP3 inflammasome activation through suppressing Nrf2 thereby increasing
You Zhou1,2,3, Yongjun Chen2, Xiaowu Zhong3
1Laboratory Medicine Center, Lanzhou University Second Hospital, Lanzhou, China.
Abstract:
Gout is a common inflammatory disease. The activation of NLRP3 inflammasome induced by monosodium urate (MSU) crystals has a critical role in gout, and its prevention is beneficial for patients. Lipoxin A4 (LXA4) is an endogenous lipoxygenase-derived eicosanoid mediator with powerful anti-inflammatory properties. However, whether LXA4 can suppress NLRP3 inflammasome activation induced by MSU crystals remains unclear. This study aimed to investigate the protective effect of LXA4 on MSU-crystal-induced NLRP3 inflammasome activation and its underlying molecular mechanisms. We found that LXA4 inhibited MSU-crystal-induced NLRP3 inflammasome activation, interleukin (IL)-1β maturation, and pyroptosis. More specifically, LXA4 suppressed the assembly of the NLRP3 inflammasome, including oligomerization and speck formation of ASC, and ASC-NLRP3 interaction. Furthermore, LXA4 suppressed oxidative stress, the upstream events for NLRP3 inflammasome activation, as evidenced by the fact that LXA4 eliminated total reactive oxygen species (ROS) generation and alleviated nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activation and mitochondrial dysfunction. However, LXA4 also depressed the Nrf2 activation, a critical molecule in the antioxidant pathway, and then exerted an inhibitory impact on Klf9 expression and promotional impact on TXNRD2 expression, two molecules located downstream of Nrf2 in sequence. Knockdown of TXNRD2 reversed the LXA4-induced depression of ROS and NLRP3 inflammasome. Moreover, LXA4 alleviated joint inflammation and decreased the production of cleaved caspase-1 and matured IL-1β in gouty arthritis rats. Taken together, our findings demonstrate that LXA4 can attenuate MSU-crystal-induced NLRP3 inflammasome activation, probably through suppressing Nrf2 activation to increase TXNRD2 expression. The present study highlights the potential of LXA4 as an attractive new gout treatment candidate.
Insights
Lipoxin A4 (LXA4) reduces gout inflammation by inhibiting NLRP3 inflammasome activation and pyroptosis. This study reveals LXA4
Area of Science:
- Immunology and Inflammation Research
- Molecular Mechanisms of Inflammatory Diseases
Background:
- Gout is a prevalent inflammatory condition.
- Monosodium urate (MSU) crystal-induced NLRP3 inflammasome activation is central to gout pathogenesis.
- Lipoxin A4 (LXA4) possesses anti-inflammatory properties, but its effect on MSU-induced NLRP3 inflammasome is unknown.
Purpose of the Study:
- To investigate the protective effects of LXA4 against MSU-crystal-induced NLRP3 inflammasome activation.
- To elucidate the underlying molecular mechanisms of LXA4's action in gout inflammation.
Main Methods:
- Assessed LXA4's impact on NLRP3 inflammasome activation, IL-1β maturation, and pyroptosis in response to MSU crystals.
- Examined LXA4's effects on oxidative stress markers (ROS, NADPH oxidase, mitochondrial dysfunction) and Nrf2 pathway.
- Utilized TXNRD2 knockdown and a rat model of gouty arthritis to validate findings.
Main Results:
- LXA4 inhibited MSU-induced NLRP3 inflammasome assembly, IL-1β maturation, and pyroptosis.
- LXA4 suppressed oxidative stress by reducing ROS generation and NADPH oxidase activity.
- LXA4 modulated the Nrf2 pathway, increasing TXNRD2 expression, which was crucial for its anti-inflammatory effects; LXA4 alleviated joint inflammation in a rat model.
Conclusions:
- LXA4 attenuates MSU-crystal-induced NLRP3 inflammasome activation and gouty arthritis.
- The mechanism involves suppressing oxidative stress and modulating the Nrf2-TXNRD2 pathway.
- LXA4 shows potential as a novel therapeutic candidate for gout treatment.
Related Concept Videos
Formation of Lipopolysaccharides
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Regulation of Nuclear Protein Sorting

